Search research articles
Contact Us
Filters
Showing results (151-160 of 196) with videos related to
Page
of 20
Sort By:
Haematologica
|
June 27, 2024
Blockade of the CD47/SIRPα checkpoint axis potentiates the macrophage-mediated antitumor efficacy of tafasitamab
Alexander Biedermann, Maria Patra-Kneuer, Dimitrios Mougiakakos, et al.
Blood
|
May 7, 2025
Augmented CD47 expression impairs alloreactive T-cell clearance after allo-HCT
Cindy Sheree Flamann, Haroon Shaikh, Carina Matos, et al.
European Journal of Immunology
|
August 5, 2021
Successful treatment of COVID-19 infection with convalescent plasma in B-cell-depleted patients may promote cellular immunity
Andreas E Kremer, Anita N Kremer, Carsten Willam, et al.
Blood
|
May 5, 2025
Expansions of circulating plasmablasts producing commensal-reactive IgA antibodies are predictors for chronic GVHD
Katharina Marie Habenicht, Jana Wanzek, Anna Bootz, et al.
Blood
|
June 12, 2025
Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma
Fabian Müller, Nora Rebecca Schwingen, Melanie Hagen, et al.
Nature Medicine
|
September 15, 2022
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
Andreas Mackensen, Fabian Müller, Dimitrios Mougiakakos, et al.
Blood
|
February 2, 2021
Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease
Yun Zhang, Lichong Shen, Katja Dreißigacker, et al.
Annals of the Rheumatic Diseases
|
August 17, 2024
CD19-CAR T-cell therapy induces deep tissue depletion of B cells
Carlo Tur, Markus Eckstein, Joachim Velden, et al.
Annals of the Rheumatic Diseases
|
January 28, 2025
CD19-CAR T-cell therapy induces deep tissue depletion of B cells
Carlo Tur, Markus Eckstein, Joachim Velden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 6, 2021
The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents
Pauline Dürr, Katja Schlichtig, Carolin Kelz, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 196) with videos related to
Sort By:
Page
of 20
Haematologica
|
June 27, 2024
Blockade of the CD47/SIRPα checkpoint axis potentiates the macrophage-mediated antitumor efficacy of tafasitamab
Alexander Biedermann, Maria Patra-Kneuer, Dimitrios Mougiakakos, et al.
Blood
|
May 7, 2025
Augmented CD47 expression impairs alloreactive T-cell clearance after allo-HCT
Cindy Sheree Flamann, Haroon Shaikh, Carina Matos, et al.
European Journal of Immunology
|
August 5, 2021
Successful treatment of COVID-19 infection with convalescent plasma in B-cell-depleted patients may promote cellular immunity
Andreas E Kremer, Anita N Kremer, Carsten Willam, et al.
Blood
|
May 5, 2025
Expansions of circulating plasmablasts producing commensal-reactive IgA antibodies are predictors for chronic GVHD
Katharina Marie Habenicht, Jana Wanzek, Anna Bootz, et al.
Blood
|
June 12, 2025
Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma
Fabian Müller, Nora Rebecca Schwingen, Melanie Hagen, et al.
Nature Medicine
|
September 15, 2022
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
Andreas Mackensen, Fabian Müller, Dimitrios Mougiakakos, et al.
Blood
|
February 2, 2021
Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease
Yun Zhang, Lichong Shen, Katja Dreißigacker, et al.
Annals of the Rheumatic Diseases
|
August 17, 2024
CD19-CAR T-cell therapy induces deep tissue depletion of B cells
Carlo Tur, Markus Eckstein, Joachim Velden, et al.
Annals of the Rheumatic Diseases
|
January 28, 2025
CD19-CAR T-cell therapy induces deep tissue depletion of B cells
Carlo Tur, Markus Eckstein, Joachim Velden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 6, 2021
The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents
Pauline Dürr, Katja Schlichtig, Carolin Kelz, et al.
Page
of 20